Research reports improvements in survival rates in patients with metastatic prostate cancer

Median Overall Survival (OS) of De Novo Metastatic Prostate Cancer in the Surveillance, Epidemiology, and End Results 17 (SEER) and Veterans Health Administration (VHA) Registries. Credit: JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.1970 Research from Saint Louis University School of Medicine finds improvements in survival in both veterans and men across the country over the last 20 years in metastatic prostate cancer, which correlate with new hormonal treatments. Martin Schoen, M.D., assistant professor of medicine and a member of the Saint Louis University AHEAD Institute, quantified trends in overall survival among Read More

Related posts:

  1. Novel liquid biopsy methodology enables monitoring of disease evolution in patients with metastatic prostate cancer
  2. Radioligand therapy extends progression-free survival with manageable safety profile in advanced prostate cancer
  3. Video: Improvements in prostate surgery
  4. Black patients more likely to experience MACE after ADT for prostate cancer
  5. Study finds suicide rates among cancer patients are falling
  6. Study finds 1 in 12 patients labeled as having ‘benign’ results actually had high-risk prostate cancer
  7. Research recommends refining the way media reports suicide
  8. Team reports on synergistic cytotoxicity of HDAC and PARP inhibitors and decitabine in pancreatic cancer cells

Leave a Reply

Your email address will not be published. Required fields are marked *